好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | Neurology in the Age of AI: What You Need to Know Now

Saturday 04/18/26
08:30 AM - 09:15 AM CDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Practice and Policy)
Brett M. Kissela, MD, MS, FAAN
Practice, Policy, and Ethics
Explore how artificial intelligence (AI) is transforming the field of neurology and what clinicians need to know today. Dr. Trey Bateman leads a timely conversation with Drs. David T. Jones and Brett Kissela, examining the current and emerging applications of AI in neurologic care, research, and education. Learn how AI is shaping clinical decision-making, patient outcomes, and the future of practice.
No CME available
Artificial Intelligence
Event Timeline
08:30 AM - 09:15 AM CDT Speaker Neurology in the Age of AI: What You Need to Know Now
Brett M. Kissela, MD, MS, FAAN, James R. Bateman III, MD, FAAN, David T. Jones, MD
Faculty Disclosures
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
James R. Bateman III, MD, FAAN Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView CME. Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EfficientCME. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to AAN interests or activities.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.